Paradoxical signal transduction in neurobiological systems

Molecular Neurobiology - Tập 24 - Trang 145-168 - 2001
Francis C. Colpaert1, Yves Frégnac2
1Centre de Recherche Pierre Fabre, Castres Cedex, France
2UPR CNRS 2191 Unité de Neurosciences Intégratives et Computationnelles (UNIC), Institut de Neurobiologie Alfred Fessard, Gif Sur Yvette, France

Tóm tắt

Information processing in neurobiological systems is commonly thought to rely on the assessment of a signal-to-noise ratio as the key mechanism of signal detection; it assumes and requires that both signal and noise are concurrently available. An alternative theory holds that detection proceeds by the system appreciating any instantaneous input by the input’s departure from the moving average of past activity. The evidence reviewed here suggests that this latter transduction mechanism provides a unique, formal account of the highly dynamic, neuroadaptative plasticity (i.e., tolerance, dependence, sensitization) that ensues upon μ-opioid receptor activation. The mechanism would appear already to operate with the receptor-G protein coupling that occurs upon agonist binding to μ-opioid receptors, and also with highly integrated responses such as whole-organism analgesia. The mechanism may perhaps operate ubiquitously with further neuronal and non-neuronal, cell surface, and intracellular-signaling systems, and may govern the experience-dependent regulation of synaptic strength. The transduction mechanism defines a continuously evolving process; the process’s most peculiar feature is that it makes any input generate not one but two outcomes that are paradoxical, or opposite in sign.

Tài liệu tham khảo

Colpaert F. C., Kuyps J. J. M. D., Niemegeers C. J. E., and Janssen P. A. (1976) Discriminative stimulus properties of fentanyl and morphine: tolerance and dependence. Pharmacol. Biochem. Behav. 5, 401–408.

Colpaert F. C. (1995) Drug discrimination: no evidence for tolerance to opiates. Pharmacol. Rev. 47, 605–629.

Rossbach M. J. (1880) Ueber die Gewöhnung an Gifte. Arch. Ges. Physiol. Tiere 21, 213–225.

Cox B. M. (1990) Drug tolerance and physical dependence, in Principles of Drug Action. The Basis of Pharmacology, (W. L. Pratt and P. Taylor, eds.) Churchill Livingstone, New York, pp. 639–690.

Koob G. F. (1996) Drug addiction: the yin and yang of hedonic homeostasis. Neuron 16, 893–896.

Nestler E. J. (1996) Under siege: the brain on opiates. Neuron 16, 897–900.

Green D. M. and Swets J. A. (1966) Signal Detection Theory and Psychophysics. John Wiley & Sons, New York.

Swets J. A. (1964) Signal Detection and Recognition by Human Observers. John Wiley & Sons, New York.

Colpaert F. C. (1978) Narcotic cue, narcotic analgesia, and the tolerance problem: the regulation of sensitivity to drug cues and to pain by an internal cue processing model, In Stimulus Properties of Drugs: Ten Years of Progress (Colpaert F. C. and Rosecrans J., eds.), Elsevier/North Holland Biomedical Press, Amsterdam, pp. 301–321.

Colpaert F. C. (1996a) System theory of pain and of opiate analgesia: no tolerance to opiates. Pharmacol. Rev. 48, 355–402.

Bruins Slot L. A. and Colpaert F. C. (1999a) Experimental realization of a signal transduction algorithm. J. Theor. Biol. 200, 39–48.

Duggan A. W. and North R. A. (1984) Electrophysiology of opioids. Pharmacol. Rev. 35, 219–281.

Cochin J. and Kornetsky C. (1964) Development and loss of tolerance to morphine in the rat after single and multiple injections. J. Pharmacol. Exp. Ther. 145, 1–10.

Yaksh T. L. and Roueihed R. (1985) The physiology and pharmacology of spinal opiates. Annu. Rev. Pharmacol. Toxicol. 25, 433–462.

Tilson H. A., Rech R. H., and Stolman S. (1973) Hyperalgesia during withdrawal as a means of measuring the degree of dependence in morphine dependent rats. Psychopharmacologia 28, 287–300.

Duttaroy A. and Yoburn B. C. (1995) The effect of intrinsic efficacy on opioid tolerance. Anesthesiology 82, 1226–1236.

Gellert V. F. and Holtzman S. G. (1978) Development and maintenance of morphine tolerance and dependence in the rat by scheduled access to morphine drinking. J. Pharmacol. Exp. Ther. 205, 536–549.

Yoburn B. C., Chen J., Huang T., and Inturrisi C. E. (1985) Pharmacokinetics and pharmacodynamics of subcutaneous morphine pellets in the rat. J. Pharmacol. Exp. Ther. 235, 282–286.

Gold L. H., Stinus L., Inturissi C. E., and Koob G. F. (1994) Prolonged tolerance, dependence and abstinence following subcutaneous morphine pellet implantation in the rat. Eur. J. Pharmacol. 253, 45–51.

Way E. L., Loh H. H., and Shen F.-H. (1969) Simultaneous quantitative assessment of morphine tolerance and physical dependence. J. Pharmacol. Exp. Ther. 167, 1–8.

Babbini M., Gaiardi M., and Bartoletti M. (1975) Persistence of chronic morphine effects upon activity in rats 8 months after ceasing the treatment. Neuropharmacology 14, 611–617.

Lett B. T. (1989) Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine and cocaine. Psychopharmacol. 98, 357–362.

Vanderschuren L. J. M. J., Tjon G. H. K., Nestby P., Mulder A. H., Schoffelmeer A. N. M., and De Vries T. J. (1997) Morphine-induced long-term sensitization to the locomotor effects of morphine and amphetamine depends on the temporal pattern of the pretreatment regimen. Psychopharmacology 131, 115–122.

Di Chiara G. and North R. A. (1992) Neurobiology of opiate abuse. Trends Pharmacol. Sci. 13, 185–193.

Kalivas P. W. and Stewart J. (1991) Dopamine transmission in drug-and stress-induced behavioral sensitization. Brain Res. Rev. 16, 223–244.

Robinson T. E. and Berridge K. C. (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 18, 247–291.

Colpaert F. C. (1979) Can chronic pain be suppressed despite purported tolerance to narcotic analgesia? Life Sci. 24, 1201–1210.

Colpaert F. C., Niemegeers C. J. E., Janssen P. A. J., and Maroli A. N. (1980) The effects of prior fentanyl administration and of pain on fentanyl analgesia: tolerance to and enhancement of narcotic analgesia. J. Pharmacol. Exp. Ther. 213, 418–424.

Kelemen K. (1973) Analgesia, tolerance and drug dependence, in Hormones and Brain Function (Lissak K., ed.), Plenum Press, New York, pp. 273–283.

Martin W. R. (1984) Pharmacology of opioids. Pharmacol. Rev. 35, 283–323.

Abbott F. V., Melzack R., and Leber B. F. (1982) Morphine analgesia and tolerance in the tailflick and formalin tests: dose-response relationships. Pharmacol. Biochem. Behav. 17, 1213–1219.

Babbini M. and Davis W. M. (1972) Time-dose relationship for locomotor activity effects of morphine after acute or repeated treatment. Br. J. Pharmacol. 46, 213–224.

Kayan S., Ferguson R. K., and Mitchell C. L. (1973) An investigation of pharmacologic and behavioral tolerance to morphine in rats. J. Pharmacol. Exp. Ther. 185, 300–306.

Rauhala P., Idänpään-Heikkilä J. J., Tuominen R. K., and Männistö P. T. (1995) Differential disappearance of tolerance to thermal, hormonal and locomotor effects of morphine in the male rat. Eur. J. Pharmacol. 285, 69–77.

Kayan S., Woods L. A., and Mitchell C. L. (1971) Morphine-induced hyperalgesia in rats tested on the hot plate. J. Pharmacol. Exp. Ther. 177, 509–513.

Mao J., Price D. D., and Mayer D. J. (1995) Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain 62, 259–274.

Kim D. H., Fields H. L., and Barbaro N. M. (1990) Morphine analgesia and acute physical dependence: rapid onset of two opposing, dose-related processes. Brain Res. 516, 37–40.

Wei E., Loh H. H., and Way E. L. (1973) Quantitative espects of precipitated abstinence in morphine-dependent rats. J. Pharmacol. Exp. Ther. 184, 398–403.

Collier H. O. J. (1980) Cellular site of opiate dependence. Nature 283, 625–629.

Koob G. F. and Bloom F. E. (1988) Cellular and molecular mechanisms of drug dependence. Science 242, 715–723.

Cheney D. L. and Goldstein A. (1971) Tolerance to opioids narcotics: time and reversibility of physical dependence in mice. Nature 232, 477–478.

Himmelsbach C. K. (1942) Clinical studies of drug addiction. Arch. Int. Med. 69, 766–772.

Hughes P. and Dragunow M. (1995) Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmacol. Rev. 47, 133–178.

Johnson S. M. and Fleming W. W. (1989) Mechanisms of cellular adaptive sensitivity changes: applications to opioid tolerance and dependence. Pharmacol. Rev. 41, 435–488.

Nestler E. J. (1992) Molecular mechanisms of drug addiction. J. Neurosci. 12, 2439–2450.

Sarne Y., Fields A., Keren O., and Gafni M. (1996) Stimulatory effects of opiates on transmitter release and possible cellular mechanisms: overview and original results. Neurochem. Res. 21, 1353–1361.

Sarne Y., Rubovitch V., Fields A., and Gafni M. (1998) Dissociation between the inhibitory and stimulatory effects of opioid peptides on cAMP formation in SK-N-SH neuroblastoma cells. Biochem. Biophys. Res. Comm. 246, 128–131.

Wang L. and Gintzler A. R. (1994) Biomodal opioid regulation of cyclic AMP formation: implications for positive and negative coupling of opiate receptors to adenylyl cyclase. J. Neurochem. 63, 1726–1730.

Fields A., Gafni M., Oron Y., and Sarne Y. (1995) Multiple effects of opiates on intracellular calcium level and on calcium uptake in three neuronal cell lines. Brain Res. 687, 94–102.

Shen K.-F. and Crain S. M. (1989) Dual opioid modulationof the action potential duration of mouse dorsal root ganglion neurons in culture. Brain Res. 491, 227–242.

Gintzler A. R. and Xu H. (1991) Different G proteins mediate the opioid inhibition of enhancement of evoked [5-methionine]enkephalin release. Proc. Natl. Acad. Sci. USA 88, 4741–4745.

Gintzler A. R., Chan W. C., and Glass J. (1987) Evoked release of methionine-enkephalin from tolerant/dependent enteric ganglia: paradoxical dependence on morphine. Proc. Natl. Acad. Sci. USA 84, 2537–2539.

Sublette E. and Gintzler A. R. (1992) Stimulus frequency and intensity: critical determinants of opioid enhancement of inhibition of evoked methionine-enkephalin release. Brain Res. 599, 165–170.

Collin E. and Cesselin F. (1991) Neurobiological mechanisms of opioid tolerance and dependence. Clin. Neuropharmacol. 14, 465–488.

Ménard D. P., van Rossum D., Kar S., Jolicoeur F. B., Jhamandas K., and Quirion R. (1995) Tolerance to the antiociceptive properties of morphine in the rat spinal cord: alteration of calcitocin generelated peptide-like immunostaining and receptor binding sites. J. Pharmacol. Exp. Ther. 273, 887–894.

Smith D. J. (1997) Dose-dependent pain-facilitatory and -inhibitory actions of neurotensin are revealed by SR 48692, a nonpeptide neurotensin antagonist: influence on the antinociceptive effect of morphine. J. Pharmacol. Exp. Ther. 282, 899–908.

Wei H., Panula P., and Pertrovaara A. (1998) A differential modulation of allodynia, hypoalgesia and nociception by neuropeptide FF in the periaqueductal gray of neuropathic rats: interaction with morphine and naloxone. Neuroscience 86, 311–319.

O’Donovan M. J. (1999) The origin of spontaneous activity in developing networks of the vertebrate nervous system. Curr. Opin. Neurobiol. 9, 94–104.

Kaufer D., Friedman A., Seidman S., and Soreg H. (1998) Acute stress facilitates long lasting changes in cholinergic gene expression. Nature 393, 373–377.

Camps M. (1998) Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase. Science 280, 1262–1265.

Evans D. R. H. and Hemmings B. A. (1998) What goes up must go down. Nature 394, 23–24.

Westphal R. S., Anderson K. A., Means R. A., and Wadzinski B. E. (1998) A signaling complex of Ca2+-calmodulin-dependent protein kinase IV and protein phosphatase 2A. Science 280, 1258–1261.

Frégnac Y. (1995) Hebbian synaptic plasticity: comparative and developmental aspects, in The Handbook for Brain Theory and Neural Networks (Arbib M. A., ed.), MIT Press, Cambridge, MA, pp. 459–464.

Turrigiano G. G. and Nelson S. B. (2000) Hebb and homeostasis in neuronal plasticity. Curr. Opin. Neurobiol. 10, 358–364.

Stent G. S. (1973) A physiological mechanism for Hebb’s postulate of learning. Proc. Natl. Acad. Sci. USA 70, 997–1001.

von der Malsburg C. (1973) Self organisation of orientation sensitive cells in the striate cortex. Kybernetik 14, 85–100.

Bear M. F. (1996) A synaptic basis for memory storage in the cerebral cortex. Proc. Natl. Acad. Sci. USA 93, 13,453–13,459.

Frégnac Y. (1998) Homeostasis or synaptic plasticity? Nature 391, 845–846.

Turrigiano G. G. (1999) Homeostatic plasticity in neuronal networks: the more things change, the more they stay the same. Trends Neurosci. 22, 221–227.

Barto A. G., Sutton R. S., and Anderson C. W. (1983) Neuron-like adaptive elements that can solve difficult learning control problems. IEEE Trans. Sys. Cyb. 13, 835–846.

Barto A. G. (1995) Reinforcement learning, in Handbook of Brain Theory and Neural Network (Arbib M.A. ed.), MIT Press, Cambridge, MA, pp. 804–809.

Bienenstock E. L., Cooper L. N., and Munro P. W. (1982) Theory for the development of neuron selectivity: orientation specificity and binocular interaction in visual cortex. Neuroscience 2, 32–48.

Foldiak P. (1989) Adaptive network for optimal linear feature extraction. Proc. IJCNN 401–406.

Foldiak P. (1990) Forming sparse representations by local anit-Hebbian learning. Biol. Cybernet. 64, 165–170.

Sejnowski T. J. (1997) Statistical constraints on synaptic plasticity. J. Theor. Biol. 69, 387–389.

Bell C. C. (1981) An efference copy which is modified by reafferent input. Science 214, 450–453.

Bell C., Bodznick D., Montgomery J., and Bastian J. (1997a) The generation and subtraction of sensory expectations within cerebellum-like structures. Behav. Brain Evol. 50, 17–31.

Von Holst E. and Mittelstaedt H. (1950) Das reafferenzprinzip (Wechselwirkungen zwischen Zentral-nervensystem und peripherie). Naturwiss 464–476.

Bell C. C., Han V., Sugarawa Y., and Sugarawa K. G. (1997b) Synaptic plasticity in a cerebellum-like structure depends on temporal order. Nature 387, 278–281.

Han V. Z., Grant K., and Bell C. C. (2000) Reversible associative depression and nonassociative potentiation at a parallel fiber synapse. Neuron 27, 611–622.

Feldman D. E. (2000) Timing-based LTP and LTD at vertical inputs to layer II/III pyramidal cells in rat barrel cortex. Neuron 27, 45–56.

Markram H., Lübke J., Frotscher M., and Sakmann B. (1997) Regulation of synaptic efficacy by coincidence of postsynaptic APs and EPSPs. Science 275, 213–215.

Turrigiano G. G., Leslie K. R., Desai N. S., Rutherford L. C., and Nelson S. G. (1998) Activity-dependent scaling of quantal amplitude in neocortical neurons. Nature 391, 892–896.

Desai N. S., Rutherford L. C., and Turrigiano G. G. (1999) Plasticity in the intrinsic excitability of cortical pyramidal neurons. Nat. Neurosci. 2, 515–520.

Stemmler M. and Koch C. (1999) How voltage-dependent conductances can adapt to maximize the information encoded by neuronal firing rate. Nat. Neurosci. 2, 521–527.

Bear M. F. (1995) Mechanisms for a sliding synaptic modification threshold. Neuron 15, 1–4.

Spitzer N. C. (1999) New dimensions of neuronal plasticity. Nat. Neurosci. 2, 489–491.

Fetz E. E. (1997) Temporal coding in neural populations? Science 278, 1901–1902.

Bear M. F., Cooper L. N., and Ebner F. F. (1987) A physiological basis for a theory of synapse modification. Science 237, 42–48.

Abraham W. C. and Bear M. F. (1996) Metaplasticity: the plasticity of synaptic plasticity. Trends Neurosci. 19, 126–130.

Christie B. R., Stellwagen D., and Abraham W. C. (1995) Reduction of the threshold for long-term potentiation by prior theta-frequency synaptic activity. Hippocampus 5, 52–59.

Haskell C. M. (1995) Cancer Treatment, 4th ed. W. B. Saunders Company, Philadelphia.

Peckham M., Pinedo H. M., and Veronesi U. (1995) Oxford Textbook of Oncology. Oxford University Press, Oxford, UK.

Pastan I. and Gottesman M. M. (1991) Multidrug resistance. Ann. Rev. Med. 42, 277–286.

Clynes M. (1994) Multiple Drug Resistance in Cancer: Cellular, Molecular and Clinical Approaches. Kluwer Academic Publishers, Dordrecht, The Netherlands.

Georges E., Sharom F. J., and Ling V. (1990) Multidrug resistance and chemosensitization: therapeutic implication for cancer chemotherapy. Adv. Pharmacol. Chemother. 21, 185–220.

Skovsgaard T., Nielsen D., Maare, A., and Wassermann K. (1994) Cellular resistance to cancer chemotherapy. Int. Rev. Cytol. 156, 77–157.

Calabro-Jones P. M., Byfield J. E., Ward J. F., and Sharp T. R. (1982) Time-dose relationship for 5-fluorouracil toxicity against human epithelial cancer cells in vivo. Cancer Res. 42, 4413–4419.

Goldie J. H., Price L. A., and Harrap K. R. (1972) Methotrexate toxicity: correlation with duration of administration, plasma levels, dose and excretion. Euro. J. Cancer 8, 409–414.

Schoenlein P. V. (1993) Molecular cytogenetics of multiple drug resistance. Cytotechnology 122, 63–89.

Dahllof B., Martinsson T., and Levan G. (1984) Resistance to actinomycin D and to vincristine induced in a SEWA mouse tumour cell line with concomitant appearance of double minutes and a low-molecular-weight protein. Exp. Cell. Res. 152, 415–426.

Lothstein L. and Horwitz S. B. (1986) Expression of phenotypic traits following modulation of colchicine resistance in J774.2 cells. J. Cell. Physiol. 127, 253–260.

Gupta R. S. (1985) Cross-resistance of vinblastine- and taxol-resistant mutants of Chinese hamster ovary cells to other anticancer drugs. Cancer Treat. Rep. 69, 515–521.

Hosking L. K., Whelan R. D. H., Shellard S. A., Davies S. L., Hickson M. K., and Hill B. T. (1994) Multiple mechanisms of resistance in a series of human testicular teratoma cell lines selected for increasing resistance to etoposide. Int. J. Cancer 57, 259–267.

Kartner N., Shales M., Riordan J. R., and Ling V. (1983) Daunorubicin-resistant Chinese hamster ovary cells expressing multidrug resistance and cell-surface P-glycoprotein. Cancer Res. 43, 4413–4419.

Rath H., Tisty T., and Schimke R. T. (1984) Rapid emergence of methotrexate resistance in cultured mouse cells. Cancer Res. 44, 3303–3306.

Volm M., Bak M. Jr., Efferth T., and Mattern J. (1988) Induced multidrug-resistance in murine sarcoma 180 cells grown in vitro and in vivo and associated changes in expression of multidrug-resistance DNA sequences and membrane glycoproteins. Anticancer Res. 8, 1169–1178.

Gerlach J. H., Kartner N., Bell D. R., and Ling V. (1986) Multidrug resistance. Cancer Surveys 5, 25–46.

Belvedere G. and Dolfini E. (1993) Studies on low-lever MDR cells. Cytotechnology 12, 257–264.

Hill B. T. (1982) Biochemical and cell kinetic aspects of drug resistance, in Drug and Hormone Resistance in Neoplasia, vol. 1, Basic Concepts (Bruchovsky N., Goldie J. H., eds.), CRC Press, Boca Raton, pp. 21–53.

Schabel F. M. (1975) Concepts for systemic treatment of micrometastases. Cancer 35, 15–24.

Shackney S. E., McCormack G. W., and Cuchural G. I. (1978) Growth rate patterns of solid tumors and their relation to responsiveness to therapy: an analytical review. Ann. Int. Med. 89, 107–121.

Skipper H. E. and Perry S. (1970) Kinetics of normal and leukemic leukocyte populations and relevance to chemotherapy. Cancer Res. 30, 1883–1897.

Committee for Proprietary Medicinal Products. (1996) Note for Guidance on Evaluation of Anticancer Medicinal Products in Man. The European Agency for the Evaluation of Medicinal Products, London.

Kerbel R. S., Kobayashi H., and Graham C. H. (1994) Intrinsic or acquired drug resistance and metastasis: are they linked phenotypes? J. Cell. Biochem. 56, 37–47.

Valeriote F., Corbett T., Edelstein M., and Baker L. (1996) New in vitro screening model for the discovery of antileukemic anticancer agents. Cancer Invest. 14, 121–141.

Glavina M. J. and Robertshaw R. (1988) Myoclonic spasms following intrathecal morphine. Anaesthesia 43, 389–390.

Morley J. S., Miles J. B., Wells J. C., and Bowsher D. (1992) Paradoxical pain. Lancet 340, 1045–1046.

Potter J. M., Reid D. B., Shaw R. J., Hackett P., and Hickmann P. E. (1989) Myoclonus associated with treatment with high doses of morphine: the role of supplemental drugs. BMJ 299, 150–153.

Sjogren P. and Eriksen J. (1994) Opioid Toxicity. Curr. Opin. Anaesthesiol. 7, 465–469.

Blum R. H., Frei E. I., and Holland J. F. (1982) Principles of dose, schedule and combination chemotherapy, in Cancer Medicine (Holland J. F. and Frei E. I., eds.), Lea and Febiger, Philadelphia, pp. 730–752.

Williams G. M., Iatropoulos M. J., Djordjevic M. V., and Kaltenberg O. P. (1993) The triphenylethylene drug tamoxifen is a strong liver carcinogen in the rat. Carcinogenesis. 14, 315–317.

Madoff L. C. and Kasper D. L. (1994) Introduction to infectious disease: host-parasite interaction, in Harrison’s Principles of Internal Medicine (Isselbacher K. J., Braunwald E., Wilson J. D., Martin J. B., Fauci A. S., Kasper D. L., eds.), McGraw-Hill, New York, pp. 485–489.

World Health Organization (1996) The World Health Report WHO, Geneva.

Dever L. A. and Dermody T. S. (1991) Mechanisms of bacterial resistance to antibiotics. Arch. Intern. Med. 151, 886–895.

Larder B. A. (1995) Viral resistance and the selection of antiretroviral combinations. J. Acquir. Immune Defic. Syndr. Hum. Retroviral. 10, S28-S33.

Vanden Bossche H., Warnock D. W., Dupont B., Kerridge D., Sen Gupta S., (1994) Improvisi I., et al. Mechanisms and clinical impact of antifungal drug resistance. J. Med. Vet. Mycol. 32, 189–220.

Borst P. and Ouelette M. (1995) New mechanisms of drug resistance in parasitic protozoa. Ann. Rev. Microbiol. 49, 427–460.

Gallo R. C. (1996) AIDS as a clinically curable disease. Cell. Pharmacol. 3, 65–67.

Montaner J. S. G., Singer J., Schechter M. T., Raboud J. M., Tsoukas C., O’Shaughnessy M., et al. (1993) Clinical correlates of in vitro HIV-1 resistance to zidovudine. Results of the Multicentre Canadian AZT trial. AIDS 7, 189–196.

Folly K. M. (1991) Clinical tolerance to opioids, in Towards a New Phamacotherapy of Pain (Basbaum A. I. and Besson J. M., eds.), John Wiley & Sons Ltd., New York, pp. 181–203.

Portenoy R. K. (1994) Opioid therapy for chronic nonmalignant pain: current status, in Progress in Pain Research Management (Fields H. L., Liebskind J. C., eds.), IASP Press, Seattle, pp. 247–287.

Twycross R. G. and McQuay H. J. (1989) Opioids, in The Textbook of Pain (Wall P. D. and Melzack R.), Churchill Livingstone, London, pp. 686–701.

Zenz M., Strumpf M., and Tryba M. (1992) Long-term opioid therapy in patients with chronic nonmalignant pain. J. Pain Sympt. Management 7, 69–77.

Nestler E. J. and Aghajanian G. K. (1997) Molecular and cellular basis of addiction. Science 278, 58–63.

Goudie A. J. (1990) Conditioned opponent processes in the development of tolerance to psychoactive drugs. Prog. Neuropsychopharmacol. Biol. Psychiatry 14, 675–688.

Siegel S. (1989) Pharmacological conditioning and drug effects, in Psychoactive Drugs: Tolerance and Sensitization (Goudie A. J. and Emmett-Oglesby M. W., eds.), Humana Press, Totowa, NJ, pp. 115–180.

Hill B. T. (1996) Drug resistance: an overview of the current state of the art. Int. J. Onc. 9, 197–203.

Bernard C. (1957) An Introduction to the Study of Experimental Medicine. (Published in 1865). Dover Publications Inc., New York.

Cannon W. B. (1932) The Wisdom of the Body. W. W. Norton, New York.

Sterling P. and Eyer J. (1988) Allostasis: a new paradigm to explain arousal pathology, in Handbook of Life Stress, Cognition and Health (Fisher S. and Reason J., eds.), John Wiley & Sons, New York, pp. 629–649.

McEwen B. S. (1998) Stress, adaptation and disease. Ann. NY Acad. Sci. 840, 33–44.

Knobil E. (1999) The wisdom of the body revisited. News Physiol. Sci. 14, 1–11.

Koob G. F. and Le Moal M. (1997) Drug abuse: hedonic homeostatic dysregulation. Science 278, 52–58.

Solomon R. L. (1980) The opponent-process theory of acquired motivation. Am. Psychol. 35, 691–712.

Bechara A., Nader K., and van der Kooy D. (1998) A two-separate-motivational-systems hypothesis of opioid addiction. Pharmacol. Biochem. Behav. 59, 1–17.

Maldonado R., Stinus L., and Koob G. F. (1996) Neurobiological Mechanisms of Opiate Withdrawal. Springer, Berlin.

Colpaert F. C. (1996b) System theory: a reply to Howard Gutstein. Pharmacol. Rev. 48, 409–411.

Bruins Slot L. A. and Colpaert F. C. (1999b) Recall rendered dependent on an opiate state. Behav. Neurosci. 113, 337–344.

Bruins Slot L. A. and Colpaert F. C. (1999c) Opiate states of memory: receptor mechanisms. J. Neurosci. 19, 10520–10529.

Colpaert F. C. (1990) Amnesic trace locked into the benzodiazepine state of memory. Psychopharmacology 102, 28–36.

Fromhold M. (1997) Fractal resistance in a transistor. Nature 386, 123–125.

Kauffman S. A. (1995) At Home in the Universe, 1st ed. Oxford University Press, Inc., Oxford, UK.

Stewart I. (1990) Does God play dice? The Mathematics of Chaos. Blackwell Publishers, London.

Thông tin
Thông tin xuất bản

Molecular Neurobiology

Tập 24

145-168

Thông tin tác giả